Teeka4

Teeka4 is a biotechnology and diagnostics company focused on providing advanced T-cell immunity testing to the public. Founded by investment analyst Teeka Tiwari, the company aims to offer a more comprehensive understanding of the human immune system's response to viral threats compared to traditional antibody tests. Its flagship product, the Teeka4 T-Cell Test, utilizes high-throughput sequencing of T-cell receptors to identify specific immune signatures associated with long-term protection. This technology is particularly relevant for assessing immunity against SARS-CoV-2, as it can detect cellular responses that remain stable even when antibody levels decline. Teeka4 positions itself as a bridge between cutting-edge genomic science and consumer health, empowering individuals with personalized data to manage their long-term wellness.